Late-onset adverse events under anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort
Journal of the American Academy of Dermatology | Jun 23, 2021
Journal of the American Academy of Dermatology | Jun 23, 2021